|
Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998. |
|||||||||||||||||||||
Lyra Therapeutics, Inc. - Common Stock (NQ:LYRA)Price and VolumeDetailed Quote
Top NewsMore News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
October 15, 2025
PerformanceMore NewsRead More
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
September 18, 2025
Upstream's New Sinus Treatment Cuts Need For Surgery, Early Trial Finds ↗
September 02, 2025
Is the Market Bullish or Bearish on Lyra Therapeutics? ↗
June 04, 2025
Lyra Therapeutics Posts 85% Q2 Loss Drop ↗
August 12, 2025
What's going on in today's session ↗
June 03, 2025
Which stocks are moving on Tuesday? ↗
June 03, 2025
Frequently Asked QuestionsIs Lyra Therapeutics, Inc. - Common Stock publicly traded?
Yes, Lyra Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Lyra Therapeutics, Inc. - Common Stock trade on?
Lyra Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lyra Therapeutics, Inc. - Common Stock?
The ticker symbol for Lyra Therapeutics, Inc. - Common Stock is LYRA on the Nasdaq Stock Market
What is the current price of Lyra Therapeutics, Inc. - Common Stock?
The current price of Lyra Therapeutics, Inc. - Common Stock is 3.410
When was Lyra Therapeutics, Inc. - Common Stock last traded?
The last trade of Lyra Therapeutics, Inc. - Common Stock was at 12/29/25 04:00 PM ET
What is the market capitalization of Lyra Therapeutics, Inc. - Common Stock?
The market capitalization of Lyra Therapeutics, Inc. - Common Stock is 108.56M
How many shares of Lyra Therapeutics, Inc. - Common Stock are outstanding?
Lyra Therapeutics, Inc. - Common Stock has 109M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
|
||||||||||||||||||||
|
|||||||||||||||||||||